Dr. Glaucomflecken Explains: Transdermal Estradiol in Prostate Cancer @NEJMgroup

Dr. Glaucomflecken Explains: Transdermal Estradiol in Prostate Cancer @NEJMgroup

Uploaded June 2026 | Updated September 2026, 1 week ago

This video in our partnership with @DGlaucomflecken explains a trial assessing the safety and efficacy of transdermal estradiol patches in patients with prostate cancer.

View the Original Article for free: https://nej.md/DrG42

#oncology #medicaleducation #NEJM

Dr. Glaucomflecken Explains: Transdermal Estradiol in Prostate Cancer

BiDil — The Story of the Black Pill

Image Challenge — May 7, 2026

High-Reliability Organizing: Refreshing a Proven Framework for Modern Health Care Challenges

Clinical Practice: Prevention and Treatment of Peanut Allergy

Dr. Glaucomflecken Explains: Rituximab versus Ocrelizumab in Relapsing Multiple Sclerosis

Could a Low-Plastic Lifestyle Lower Plastic Levels in our Body?

Three Studies That Made Headlines in May

Clinical Practice: Fibromyalgia

Dr. Glaucomflecken Explains: Intensive LDL Cholesterol Targeting in Atherosclerotic CVD (Ez-PAVE)

Clinical Problem-Solving: Too Much of a Good Thing

NEJM Clinician: Are PPIs Linked to COPD Flares?

Dr. Glaucomflecken Explains: Transdermal Estradiol in Prostate Cancer